~~<i id='C83D214198'><strike id='C83D214198'><tt id='C83D214198'><pre id='C83D214198'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

focus

author：entertainment 2025-10-01 17:21:15 - browse：1

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH.

The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

focus

leisure time

focus

knowledge

entertainment

leisure time

VicePresidentKamalaHarrisstandsasHouseSpeakerMikeJohnsonofLouisianawatchesasPresidentBidendeliversth

WSS

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

HHS suspends federal funding for EcoHealth Alliance

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

HHS suspends federal funding for EcoHealth Alliance

IVF, abortion rights issues kick off Biden’s State of the Union

STAT series 'Denied by AI' wins major journalism prizes

knowledge

focus

focus

Hollywood unions extend contract negotiations for actors

Amylyx ALS drug fails large clinical trial

Medical records are filled with copy

Novo Nordisk testing Wegovy against alcohol

Medical records are filled with copy

What a koala virus tells us about the human genome

After affirmative action ruling, medical educators look to 'holistic review'

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Alkermes shareholders re

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

leisure time

WuXi Biologics execs register to lobby as Congress comes for the company

Boston hospital trains restaurant workers on naloxone for overdoses

Lilly’s weekly insulin works as well as daily products, new studies show

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Change Healthcare cyberattack prompts Medicare loan program

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

focus

knowledge

entertainment

leisure time